An evolving understanding of the risks and benefits of HRT has led to a reevaluation of the role of HRT for breast cancer survivors.

For decades, breast cancer survivors going through menopause have been told that hormone therapy is off-limits—full stop. But new analyses and a 2025 expert consensus paper suggest that there may be ...

HRT does not increase breast cancer risk in BRCA1/BRCA2 variant carriers, with lower incidence in users versus non-users. Estrogen-alone therapy is linked to reduced mortality, while estrogen plus ...

NEW YORK (Reuters Health) - Invasive breast cancer rates have fallen since the substantial decline in postmenopausal hormone replacement therapy (HRT) occurred, even after a decline in breast cancer ...